Antonow-Schlorke Iwa, Müller Thomas, Brodhun Michael, Wicher Carola, Schubert Harald, Nathanielsz Peter W, Witte Otto W, Schwab Matthias
Department of Neurology, Friedrich Schiller University, Jena, Germany.
Am J Obstet Gynecol. 2007 Jun;196(6):553.e1-6. doi: 10.1016/j.ajog.2006.10.898.
The purpose of this study was to examine whether glucocorticoid effects on neuronal cytoskeleton, which we have shown previously at 0.87 gestation when the hypothalamo-pituitary-adrenal axis matures, are age-dependent and reversible.
Fetal sheep received 3.3 microg kg(-1) h(-1) betamethasone (n = 10) or saline solution (n = 9) intravenously over 48 hours at 0.75 gestation (ie, before the hypothalamo-pituitary-adrenal axis matures and when betamethasone is administered clinically).
Betamethasone diminished microtubule-associated protein (MAP) 1B and 2 immunoreactivity in the frontal neocortex and caudate putamen (P < .05) and MAP2 in the hippocampus (P < .05), which is similar to the effects that are seen at 0.87 gestation. In agreement, the number of glucocorticoid receptors did not differ at both ages. Loss of MAP1B and MAP2 immunoreactivity was not accompanied by neuronal death and was reversible within 24 hours.
Alteration of neuronal cytoskeletal proteins caused by antenatal betamethasone exposure is transient and independent of age during late gestation.
本研究旨在探讨糖皮质激素对神经元细胞骨架的影响是否具有年龄依赖性及可逆性,此前我们已证实在妊娠0.87时(下丘脑 - 垂体 - 肾上腺轴成熟)存在这种影响。
在妊娠0.75时(即下丘脑 - 垂体 - 肾上腺轴成熟之前且临床上使用倍他米松时),给胎羊静脉注射3.3微克/千克/小时的倍他米松(n = 10)或生理盐水(n = 9),持续48小时。
倍他米松使额叶新皮质和尾状壳核中的微管相关蛋白(MAP)1B和2免疫反应性降低(P <.05),海马中的MAP2免疫反应性降低(P <.05),这与妊娠0.87时所见的效应相似。同样,两个年龄段的糖皮质激素受体数量没有差异。MAP1B和MAP2免疫反应性的丧失并未伴随神经元死亡,且在24小时内可逆转。
产前暴露于倍他米松引起的神经元细胞骨架蛋白改变是短暂的,且在妊娠晚期与年龄无关。